BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37793562)

  • 41. High shear induces platelet dysfunction leading to enhanced thrombotic propensity and diminished hemostatic capacity.
    Chen Z; Mondal NK; Zheng S; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
    Platelets; 2019; 30(1):112-119. PubMed ID: 29182470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation.
    Michels A; Swystun LL; Mewburn J; Albánez S; Lillicrap D
    J Vis Exp; 2017 Aug; (126):. PubMed ID: 28829426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anti-platelet adhesive effect and mechanisms of Xueshuantong capsules under flow conditions].
    Han SX; Chen Y; Zhang Q; Han B; Ge YM; Xiang YH; Liao FL; You Y
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(2):341-346. PubMed ID: 28948741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
    Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
    Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glycoprotein (GP) Ib-IX-transfected cells roll on a von Willebrand factor matrix under flow. Importance of the GPib/actin-binding protein (ABP-280) interaction in maintaining adhesion under high shear.
    Cranmer SL; Ulsemer P; Cooke BM; Salem HH; de la Salle C; Lanza F; Jackson SP
    J Biol Chem; 1999 Mar; 274(10):6097-106. PubMed ID: 10037692
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions.
    Kuijper PH; Gallardo Torres HI; van der Linden JA; Lammers JW; Sixma JJ; Koenderman L; Zwaginga JJ
    Blood; 1996 Apr; 87(8):3271-81. PubMed ID: 8605343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bioreactivity of stent material: Activation of platelets, coagulation, leukocytes and endothelial cell dysfunction in vitro.
    Ollivier V; Roques C; Receveur N; Gratz M; Feldman L; Letourneur D; Gachet C; Mangin PH; Jandrot-Perrus M
    Platelets; 2017 Sep; 28(6):529-539. PubMed ID: 28032527
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discrete responses of erythrocytes, platelets, and von Willebrand factor to shear.
    Chan CHH; Simmonds MJ; Fraser KH; Igarashi K; Ki KK; Murashige T; Joseph MT; Fraser JF; Tansley GD; Watanabe N
    J Biomech; 2022 Jan; 130():110898. PubMed ID: 34896790
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
    Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspirin has limited ability to modulate shear-mediated platelet activation associated with elevated shear stress of ventricular assist devices.
    Valerio L; Tran PL; Sheriff J; Brengle W; Ghosh R; Chiu WC; Redaelli A; Fiore GB; Pappalardo F; Bluestein D; Slepian MJ
    Thromb Res; 2016 Apr; 140():110-117. PubMed ID: 26938158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress.
    Bernardo A; Ball C; Nolasco L; Choi H; Moake JL; Dong JF
    J Thromb Haemost; 2005 Mar; 3(3):562-70. PubMed ID: 15748247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H; Sturgeon SA; Jackson SP; Hamilton JR
    Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulatory loop design and components introduce artifacts impacting in vitro evaluation of ventricular assist device thrombogenicity: A call for caution.
    Li M; Walk R; Roka-Moiia Y; Sheriff J; Bluestein D; Barth EJ; Slepian MJ
    Artif Organs; 2020 Jun; 44(6):E226-E237. PubMed ID: 31876310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Shear-induced platelet adherence and activation in an in-vitro dynamic multiwell-plate system.
    Reinthaler M; Johansson JB; Braune S; Al-Hindwan HSA; Lendlein A; Jung F
    Clin Hemorheol Microcirc; 2019; 71(2):183-191. PubMed ID: 30584128
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.
    Lev EI; Estrov Z; Aboulfatova K; Harris D; Granada JF; Alviar C; Kleiman NS; Dong JF
    Thromb Haemost; 2006 Oct; 96(4):498-504. PubMed ID: 17003929
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
    Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
    Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelets: physiology and biochemistry.
    Jurk K; Kehrel BE
    Semin Thromb Hemost; 2005; 31(4):381-92. PubMed ID: 16149014
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Matrix metalloproteinase-2 enhances platelet deposition on collagen under flow conditions.
    Guglielmini G; Appolloni V; Momi S; De Groot PG; Battiston M; De Marco L; Falcinelli E; Gresele P
    Thromb Haemost; 2016 Jan; 115(2):333-43. PubMed ID: 26510894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Platelet--vessel wall interactions].
    Baruch D
    Therapie; 2006; 61(5):371-8. PubMed ID: 17243265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.
    Zwaginga JJ; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(1):49-61. PubMed ID: 2297347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.